The stock of Nano X Imaging Ltd (NASDAQ:NNOX) last traded at $6.31, up 2.44% from the previous session.
Data from the available sources indicates that Nano X Imaging Ltd (NASDAQ:NNOX) is covered by 3 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and a low of $14.50, we find $26.50. Given the previous closing price of $6.16, this indicates a potential upside of 330.19 percent. NNOX stock price is now 1.70% away from the 50-day moving average and -36.82% away from the 200-day moving average. The market capitalization of the company currently stands at $361.50M.
In total, 0 analysts have assigned it a hold rating, and 3 have given it a buy rating. Brokers who have rated the stock have averaged $23.67 as their price target over the next twelve months.
With the price target of $14.50, Alliance Global Partners recently initiated with Buy rating for Nano X Imaging Ltd (NASDAQ: NNOX).
A total of 10.83% of the company’s stock is owned by insiders.
During the past 12 months, Nano X Imaging Ltd has had a low of $4.89 and a high of $22.69. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 3.31, and a quick ratio of 3.31. The fifty day moving average price for NNOX is $6.20 and a two-hundred day moving average price translates $9.99 for the stock.
The latest earnings results from Nano X Imaging Ltd (NASDAQ: NNOX) was released for Jun, 2023. According to the Medical Devices Company, earnings per share came in at -$0.31, missing analysts’ expectations of -$0.26 by -0.05. This compares to -$0.38 EPS in the same period last year. The net profit margin was -969.77% and return on equity was -40.84% for NNOX. The company reported revenue of $2.58 million for the quarter, compared to $2.2 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 17.36 percent. For the current quarter, analysts expect NNOX to generate $3.3M in revenue.
Nano X Imaging Ltd(NNOX) Company Profile
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company’s solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company was incorporated in 2018 and is based in Neve Ilan, Israel.
